Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
| Autor: | Tao, Y., Biau, J., Sun, X.S., Sire, C., Martin, L., Alfonsi, M., Prevost, J.B., Modesto, A., Lafond, C., Tourani, J.M., Miroir, J., Kaminsky, M.C., Coutte, A., Liem, X., Chautard, E., Vauleon, E., Drouet, F., Ruffier, A., Ramee, J.F., Waksi, G., Péchery, A., Wanneveich, M., Guigay, J., Aupérin, A., Bourhis, J. |
|---|---|
| Zdroj: | In Annals of Oncology January 2023 34(1):101-110 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|